← Leaderboards
David C Linehan
University Of Rochester
$5,269,651
Attributed
$6,072,551
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,072,551 · 9
By mechanism
R01$5,196,732 · 2
K08$624,435 · 1
P30$211,524 · 2
P41$39,860 · 4
Top collaborators
- Scott Andrew Gerber4 shared
Most similar at University Of Rochester
Same institution · by research overlap
- Minsoo Kim$21,000,281
- Scott Andrew Gerber$4,201,154
- Benjamin Matthew Segal$9,506,634
- Richard E Waugh$11,805,785
- Daniel A Hammer$18,014,094
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsClinical TrialsImmunePancreatic Ductal AdenocarcinomaCessation Of LifeMalignant Neoplasm Of PancreasMyeloid CellsPeripheral BloodTumor MicroenvironmentTumorMediatingEffective TherapyCancer EtiologyPre-Clinical ModelExcisionMalignant NeoplasmsOperative Surgical ProceduresBeta-ChemokinesMonocyteInflammatoryMouse ModelNeoplastic CellBone MarrowBlood
Grant awards (27)
Clinical Protocol and Data Management$135,585
P30 · FY2025 · CA · contact PI
Repolarizing the Tumor and Metastatic Microenvironments to Treat Patients with Pancreatic Cancer$83,487
R01 · FY2025 · CA
Protocol Review and Monitoring System$75,939
P30 · FY2025 · CA · contact PI
Repolarizing the Tumor and Metastatic Microenvironments to Treat Patients with Pancreatic Cancer$490,237
R01 · FY2024 · CA
Modulating innate immune cells in the tumor microenvironment of pancreas cancer to enhance anti-tumor immunity$334,305
R01 · FY2023 · CA · contact PI
Repolarizing the Tumor and Metastatic Microenvironments to Treat Patients with Pancreatic Cancer$516,038
R01 · FY2022 · CA
Modulating innate immune cells in the tumor microenvironment of pancreas cancer to enhance anti-tumor immunity$338,099
R01 · FY2022 · CA · contact PI
Modulating innate immune cells in the tumor microenvironment of pancreas cancer to enhance anti-tumor immunity$522,237
R01 · FY2021 · CA · contact PI
Repolarizing the Tumor and Metastatic Microenvironments to Treat Patients with Pancreatic Cancer$516,038
R01 · FY2021 · CA
Modulating innate immune cells in the tumor microenvironment of pancreas cancer to enhance anti-tumor immunity$351,098
R01 · FY2020 · CA · contact PI
Modulating innate immune cells in the tumor microenvironment of pancreas cancer to enhance anti-tumor immunity$118,067
R01 · FY2020 · CA · contact PI
Modulating innate immune cells in the tumor microenvironment of pancreas cancer to enhance anti-tumor immunity$349,385
R01 · FY2019 · CA · contact PI
CCR2 BLOCKADE IN HUMAN PANCREATIC CANCER$319,377
R01 · FY2017 · CA · contact PI
CCR2 BLOCKADE IN HUMAN PANCREATIC CANCER$318,513
R01 · FY2016 · CA · contact PI
CCR2 BLOCKADE IN HUMAN PANCREATIC CANCER$318,513
R01 · FY2015 · CA · contact PI
CCR2 BLOCKADE IN HUMAN PANCREATIC CANCER$305,938
R01 · FY2014 · CA · contact PI
CCR2 BLOCKADE IN HUMAN PANCREATIC CANCER$315,400
R01 · FY2013 · CA · contact PI
IDENTIFICATION OF PROGNOSTIC BIOMARKERS IN PANCREAS CANCER$6,075
P41 · FY2011 · RR · contact PI
IDENTIFICATION OF PROGNOSTIC BIOMARKERS IN PANCREAS CANCER$14,575
P41 · FY2010 · RR · contact PI
IDENTIFICATION OF PROGNOSTIC BIOMARKERS IN PANCREAS CANCER$5,825
P41 · FY2009 · RR · contact PI
IDENTIFICATION OF PROGNOSTIC BIOMARKERS IN PANCREAS CANCER$13,385
P41 · FY2008 · RR · contact PI
Multivalent Dendritic Cell Vaccine in Pancreas Cancer$62,444
K08 · FY2006 · CA · contact PI
Multivalent Dendritic Cell Vaccine in Pancreas Cancer$124,887
K08 · FY2005 · CA
Multivalent Dendritic Cell Vaccine in Pancreas Cancer$124,887
K08 · FY2004 · CA
Multivalent Dendritic Cell Vaccine in Pancreas Cancer$124,887
K08 · FY2003 · CA
Multivalent Dendritic Cell Vaccine in Pancreas Cancer$62,443
K08 · FY2002 · CA
Multivalent Dendritic Cell Vaccine in Pancreas Cancer$124,887
K08 · FY2001 · CA